Clinical trials
1 active trial in the US
Recruiting, about to start, or running now.
- A Prospective Cohort Study to Evaluate the Safety, Efficacy, and Usability of the EpiZact Device NCT06729255
Updated
Reviewed by Chandani Patel
US Acute Care Needleless Connectors Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Mechanism, By Connector Type, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$141.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $217.1 Mn | — | — |
| 2025 (base) | $229.1 Mn | +$11.9 Mn | — |
| 2026 (forecast) | $241.7 Mn | +$12.6 Mn | +5.5% |
| 2027 (forecast) | $255.0 Mn | +$13.3 Mn | +11.3% |
| 2028 (forecast) | $269.0 Mn | +$14.0 Mn | +17.4% |
| 2029 (forecast) | $283.8 Mn | +$14.8 Mn | +23.9% |
| 2030 (forecast) | $299.4 Mn | +$15.6 Mn | +30.7% |
| 2031 (forecast) | $315.8 Mn | +$16.5 Mn | +37.9% |
| 2032 (forecast) | $333.2 Mn | +$17.4 Mn | +45.5% |
| 2033 (forecast) | $351.5 Mn | +$18.3 Mn | +53.5% |
| 2034 (forecast) | $370.9 Mn | +$19.3 Mn | +61.9% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $229.1 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $370.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.5% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Mechanism, connector type and end user (see all) |
| Key players | B. Braun Melsungen AG, Baxter International, BD (Becton, Dickinson), Cardinal Health, CareFusion Corporation and 2 more (see all) |
| Regulator in the US | FDASource: US Food and Drug Administration. Checked 14 Nov 2026. |
| Active clinical trials | 1 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Acute Care Needleless Connectors are medical devices that are used to establish access points to tips of vascular catheters for introducing fluids as well as drawing out material without necessarily using needles. These connectors are important, particularly in the acute care, to reduce patient risk and protect staff from needle stick injuries.
The acute care needleless connectors market has grown because there is a need to minimize Healthcare-Associated Infections and conform to the regulatory requirements. These devices are used to avoid complications such as needle-stick injuries, especially in acute-care situations including hospitals and emergency departments. North America dominates the market, while the Asia-Pacific region is the fastest-growing, attributed to increasing healthcare expenditures. Integration of new technologies, increased concern for the safety of patients and allowing market competition has its advantages while such factors as high price and specificity of use may cause obstacles to creating a successful market in some areas. Some of the market leaders are ICU Medical, BD, and B. Braun.
New needleless connector designs are also improving performance and reducing risk of infection, including the issue of efficient fluid displacement. The key factors that are propelling the demand for these devices are the increasing expenditure on healthcare across the globe and the governments having strict policies related to cases of diseases. There is an increasing awareness of the value and application of these technologies among the healthcare professionals, due to their ability to prevent situations like needle stick injuries or cases of catheter related bloodstream infections (CRBSI). These connectors are getting popular in intravenous administration of medicines and blood sampling.
There are future prospects for applications of the needleless connectors to increase its usage in hospitals, clinics, and homecare as they opt for enhanced patient safety. Technological developments in the connector designs and the materials used, especially for better displacement of fluid and infection control, are imperative for the future growth of the market. Furthermore, the increase in global healthcare spending, especially in the developed nations, and the expansion in demand in the emergent nations with a quickly progressing healthcare sector are additional opportunities within the market.
Lack of adequate training on the use of these devices may lead to wrong application and increased problems like infection transmission and catheter-related bloodstream infections (CRBSI). The designs of some connectors can in fact be intricate and this can also discourage their use because small intricate connectors are hard to use especially during emergencies such as in emergency department. However, some factors that still restrain the market rise include the fact that sophisticated systems are expensive, and due to these costs, some institutions especially in the developing world may opt for the low-end varieties.
March 2024, Medtronic Neurosurgery Recalled Duet External Drainage and Monitoring System Catheter Tubing due to a Potential for the Catheter Disconnection from the Patient Line Stopcock Connectors.
December 2025, B. Braun Medical Inc., a leader in smart infusion therapy and pain management, announced the launch of its new CARESITE MicroTM Luer Access Device, designed to reduce exposure to harmful chemicals and decrease infection risk, making IV access for patients and healthcare providers.
October 2025, The PIVO™ Pro Needle-free Blood Collection Device is designed to achieve the first and only compatibility with integrated and long peripheral IV catheters, including the new Nexiva™ Closed IV Catheter System with NearPort™ IV Access in addition to traditional short IV catheters.
August 2021, PuraCath Medical, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced that it has received 510(k) clearance for its FireFly Needleless Connector from the USFDA. The Firefly Needleless Connector is a sterile single patient use connector for needleless access to the IV line and IV catheter during IV therapy and can be used for direct injection, intermittent infusion, continuous infusion or aspiration.
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2] ClinicalTrials.gov lists 1 study on Acute Care Needleless Connectors that is recruiting, active or about to start in the US.[3]
[1] US Food and Drug Administration. Checked 14 Nov 2026.
[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.
Needleless connectors are being prescribed in institutions by virtue of Policy/Regulation modification from OSHA among others which recommend the use of needleless connectors in a bid to reduce needlestick injuries and improve patient outcomes. Other measures related to infection control by governments and health organizations also contribute to the need for safer medical devices, propelling the demand for needleless connectors. Furthermore, funding programs in some parts of the globe help healthcare centres to purchase such sophisticated instruments. With regards to reimbursement, changes in insurance policies and transitions to value-based care systems are encouraging the use of needleless connectors by eliminating or decreasing costs. Research on the cost-saving impact that averaged decreased infections and improved patient experiences could widen insurance acceptance and coverage.
What doctors and scientists are doing in Acute Care Needleless Connectors right now, from free public sources.
1 active trial in the US
Recruiting, about to start, or running now.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
From our blog
Healthcare Services · US
Healthcare Services · US
Pharmaceuticals · US
OTC & Nutraceuticals · US
Pharmaceuticals · US
Healthcare Services · US